Why the study?
Does aspirin improve platelet survival time and reverse platelet consumption in patients with thrombocythemia complicated by erythromelalgia?
Population
26 subjects, comprising 10 patients with thrombocythemia complicated by erythromelalgia, 10 asymptomatic…
Comparison
Aspirin vs Pre-treatment baseline
Design
Cohort
Authors
Loading...
Aspirin may improve platelet kinetics in erythromelalgia with thrombocythemia; leaves open whether this reduces clinical events in randomized trials.
Does aspirin improve platelet survival time and reverse platelet consumption in patients with thrombocythemia complicated by erythromelalgia?
Aspirin effectively reverses the increased platelet consumption and microvascular thrombosis associated with erythromelalgia in patients with thrombocythemia.
Genderen et al. (1995) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: